Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Junevity is a biotechnology company developing cell reset therapeutics for longevity. Using its RESET platform, which combines large-scale human data and AI, the company identifies transcription factor targets and represses them with siRNA therapeutics. Junevity focuses on treating Type 2 diabetes, obesity, frailty, and other age-related diseases. Founded in 2023 out of UCSF and based in San Francisco, its mission is to advanc...
Junevity is a biotechnology company developing cell reset therapeutics for longevity. Using its RESET platform, which combines large-scale human data and AI, the company identifies transcription factor targets and represses them with siRNA therapeutics. Junevity focuses on treating Type 2 diabetes, obesity, frailty, and other age-related diseases. Founded in 2023 out of UCSF and based in San Francisco, its mission is to advance siRNA therapeutics for a longer, healthier lifespan.

List your booth number for exhibitions, ask us